In vivo protection against endotoxin by plasma high density lipoprotein

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Septic shock, a severe complication of bacterial infections, leads to high mortality rates.
• Cytokines, triggered by endotoxin from Gram-negative bacteria, drive septic shock symptoms.
• Current treatments targeting endotoxin or cytokines show limited efficacy.

Purpose of the Study:

• To investigate the protective role of high-density lipoprotein (HDL) against endotoxin-induced septic shock in vivo.
• To determine if elevated plasma HDL levels enhance endotoxin neutralization and improve survival.
• To evaluate the efficacy of reconstituted HDL and its components in preventing endotoxin toxicity.

Main Methods:

• Utilized transgenic mice with elevated plasma HDL concentrations.
• Administered reconstituted HDL (rHDL) and its components (apolipoprotein A-I mimetic peptide) intravenously.
• Measured endotoxin binding to HDL, plasma cytokine levels, and survival rates.

Main Results:

• Mice with higher HDL levels exhibited increased endotoxin binding to HDL and reduced plasma cytokine levels.
• Elevated HDL concentrations significantly improved survival rates in endotoxin-challenged mice.
• Administering rHDL, particularly with an apolipoprotein A-I mimetic peptide, conferred protection, while intact HDL showed mild toxicity and apoprotein alone was ineffective.

Conclusions:

• Plasma HDL plays a crucial role in neutralizing endotoxin and protecting against septic shock.
• Augmenting HDL levels or administering specific reconstituted HDL formulations can enhance endotoxin neutralization.
• A simple model suggests HDL's phospholipid surface facilitates lipopolysaccharide binding and neutralization.